Sponsor Pipeline

Adlai Nortye Biopharma Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
Active Trials by Phase
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT04999384 First in Human, Dose Escalation Study of AN4005 Advanced Solid Tumor Recruiting
NCT07252479 Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid… Solid Tumors (Phase 1) Recruiting
NCT07639047 An Initial Evaluation of AN8025 in Solid Tumors Advanced Solid Tumor (Phase 1) Recruiting
NCT07686445 A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression Solid Tumor (Phase I) Not Yet Recruiting
Get alerts when Adlai Nortye Biopharma Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free